Continue Reading
Full article on Bloomberg
Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal
Market Intelligence Analysis
AI-Powered
Why This Matters
Abbott Laboratories is issuing corporate bonds to fund its $21 billion acquisition of Exact Sciences Corp, a cancer-screening company.
Market Impact
Market impact analysis based on neutral sentiment with 80% confidence.
Sentiment
Neutral
AI Confidence
80%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Abbott Laboratories is selling corporate bonds in as many as eight parts to help fund its around $21 billion acquisition of cancer-screening company Exact Sciences Corp.
Original article published by
Bloomberg
on February 23, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.